We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PCSB
1026
DELISTED
PCSB Financial Corporation
PCSB
$202K ﹤0.01%
10,000
CRUS icon
1027
Cirrus Logic
CRUS
$6.87B
$201K ﹤0.01%
2,443
+2,392
+4,690% +$162K
FCN icon
1028
FTI Consulting
FCN
$5.04B
$201K ﹤0.01%
1,822
+159
+10% +$17.4K
JKHY icon
1029
Jack Henry & Associates
JKHY
$11.2B
$201K ﹤0.01%
1,386
-49
-3% -$7.16K
POWI icon
1030
Power Integrations
POWI
$3.3B
$201K ﹤0.01%
4,068
+30
+0.7% +$1.38K
WCN
1031
Waste Connections
WCN
$42.7B
$199K ﹤0.01%
2,198
S
1032
DELISTED
Sprint Corporation
S
$199K ﹤0.01%
38,466
-672
-2% -$3.94K
LUMN icon
1033
Lumen
LUMN
$6.38B
$198K ﹤0.01%
15,095
-11,539
-43% -$155K
MFC icon
1034
Manulife Financial
MFC
$74.2B
$198K ﹤0.01%
9,844
-287
-3% -$5.48K
RIVE
1035
DELISTED
Riverview Financial Corporation Common Stock
RIVE
$197K ﹤0.01%
15,788
-236
-1% -$2.76K
IOVA icon
1036
Iovance Biotherapeutics
IOVA
$2.1B
$194K ﹤0.01%
7,030
+325
+5% +$7.39K
MS.PRE icon
1037
Morgan Stanley Series E Preferred Stock
MS.PRE
$876M
$194K ﹤0.01%
6,795
+1,500
+28% +$43.5K
CBT icon
1038
Cabot Corp
CBT
$4.7B
$193K ﹤0.01%
4,073
+19
+0.5% +$881
EP.PRC icon
1039
El Paso Energy Capital Trust I
EP.PRC
$223M
$193K ﹤0.01%
3,765
GATX icon
1040
GATX Corp
GATX
$6.6B
$192K ﹤0.01%
2,330
VNO icon
1041
Vornado Realty Trust
VNO
$7.54B
$191K ﹤0.01%
2,883
+443
+18% +$28.6K
COLM icon
1042
Columbia Sportswear
COLM
$3.3B
$189K ﹤0.01%
1,891
VTR icon
1043
Ventas
VTR
$47.7B
$188K ﹤0.01%
3,289
-12,500
-79% -$785K
NATI
1044
DELISTED
National Instruments Corp
NATI
$188K ﹤0.01%
4,443
CHK
1045
DELISTED
Chesapeake Energy Corporation
CHK
$188K ﹤0.01%
1,139
-17
-1% -$3.42K
CHT icon
1046
Chunghwa Telecom
CHT
$33.5B
$186K ﹤0.01%
5,046
-97
-2% -$3.58K
FRPH icon
1047
FRP Holdings
FRPH
$448M
$186K ﹤0.01%
7,500
CRL icon
1048
Charles River Laboratories
CRL
$11.6B
$184K ﹤0.01%
1,206
+952
+375% +$132K
KN icon
1049
Knowles
KN
$3.07B
$183K ﹤0.01%
8,695
+8,060
+1,269% +$173K
KRC icon
1050
Kilroy Realty
KRC
$4.5B
$183K ﹤0.01%
2,182
-35
-2% -$2.85K

Similar funds

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.